Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04628000 · ClinicalTrials.gov registry record
Baseline Vitamin D Deficiency and COVID-19 Disease Severity
A clinical trial of COVID-19 and Vitamin D Deficiency, sponsored by Parkview Medical Center.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT04628000: Completed study of COVID-19 and Vitamin D Deficiency, sponsored by Parkview Medical Center.
NCT04628000 is a study of COVID-19 and Vitamin D Deficiency that has completed, run by Parkview Medical Center. The registered enrollment target is 50 participants, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04628000, a study of COVID-19 and Vitamin D Deficiency, has completed, sponsored by Parkview Medical Center.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
It is known that vitamin D has been found to decrease incidence of viral respiratory infections, as well as have effects on multiple cytokines involved in immunomodulation and the bradykinin/renin-angiotensin system. Recently, data was released showing a correlation between baseline vitamin D deficiency status and increased risk of contracting COVID-19. Separate analysis shows that many of the deleterious effects of COVID-19 may be due to the bradykinin/RAS system, and that vitamin D is one plausible treatment option to modulate these effects. Studies are currently ongoing to determine if vitamin D supplementation of those hospitalized with COVID-19 has a beneficial effect on patient outcomes. Healthcare resources have been strained during the pandemic in areas of heavy caseload. It is possible that those with concurrent vitamin D deficiency and COVID positivity have an increased need for escalation of care. A small study has been conducted in this area, but was limited by small number of subjects.
Primary Outcome
Length of stay
Conditions Studied
Interventions
- OTHER Vitamin D
Study Locations (1)
Colorado
- Parkview Medical Center - Pueblo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-10-27 |
| Est. Completion | 2022-04-14 |
What the finished NCT04628000 record still lists
NCT04628000 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Vitamin D is the first listed.
NCT04628000 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04628000 about?
NCT04628000 is a clinical study titled "Baseline Vitamin D Deficiency and COVID-19 Disease Severity". It is known that vitamin D has been found to decrease incidence of viral respiratory infections, as well as have effects on multiple cytokines involved in immunomodulation and the bradykinin/renin-angiotensin system. Recently, data was released showing a correlation between baseline vitamin D defic...
What is the current status of trial NCT04628000?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2020-10-27. Estimated completion is 2022-04-14.
What conditions does trial NCT04628000 study?
This clinical trial studies the following conditions: COVID-19, Vitamin D Deficiency.
What interventions are being tested in trial NCT04628000?
The interventions under investigation include: Vitamin D (OTHER).
Who is sponsoring clinical trial NCT04628000?
This trial is sponsored by Parkview Medical Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04628000 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04628000's enrollment target sits among peer trials
50 245th of 298 higher than 50 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI